NASDAQ: NTLAIntellia Therapeutics Inc Stock Ownership - Who owns Intellia Therapeutics?
Insider buying vs selling
Have Intellia Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| James Basta | EVP General Counsel | 2025-03-04 | 2,572 | $8.99 | $23.12kSell |
| Eliana Clark | EVP Chief Technical Officer | 2025-03-04 | 679 | $8.99 | $6.10kSell |
| Muna Bhanji | Director | 2025-01-29 | 265 | $9.97 | $2.64kSell |
| David Lebwohl | EVP Chief Medical Officer | 2025-01-03 | 9,557 | $12.18 | $116.40kSell |
| Laura Sepplorenzino | EVP Chief Scientific Officer | 2025-01-03 | 8,966 | $12.18 | $109.21kSell |
| Eliana Clark | EVP Chief Technical Officer | 2025-01-03 | 7,422 | $12.18 | $90.40kSell |
| John M. Leonard | President and CEO | 2025-01-03 | 26,807 | $12.18 | $326.51kSell |
| James Basta | EVP General Counsel | 2025-01-03 | 7,074 | $12.18 | $86.16kSell |
| Michael P. Dube | VP Chief Accounting Officer | 2025-01-03 | 1,372 | $12.18 | $16.71kSell |
| Derek Hicks | EVP Chief Business Officer | 2025-01-03 | 6,502 | $12.18 | $79.19kSell |
NTLA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NTLA insiders and whales buy or sell their stock.
NTLA Shareholders
What type of owners hold Intellia Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ark Investment Management LLC | 12.11% | 12,536,386 | $112.83M | Institution |
| Blackrock Inc | 10.49% | 10,857,693 | $97.72M | Institution |
| Vanguard Group Inc | 9.84% | 10,190,053 | $91.71M | Institution |
| Rachel E. Haurwitz | 5.40% | 5,593,846 | $50.34M | Insider |
| Caribou Therapeutics Holdco LLC | 5.40% | 5,593,846 | $50.34M | Insider |
| State Street Corp | 5.03% | 5,205,698 | $46.85M | Institution |
| Novartis Institutes For Biomedical Research Inc | 4.20% | 4,352,295 | $39.17M | Insider |
| Caribou Biosciences Inc | 3.86% | 3,994,355 | $35.95M | Insider |
| Morgan Stanley | 3.68% | 3,814,546 | $34.33M | Institution |
| Atlas Venture Associates IX LP | 3.60% | 3,729,788 | $33.57M | Insider |
NTLA vs Biotech Stocks
Intellia Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.